{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 16, "transaction_limit": 160, "filters": {"q": "", "ticker": "HALO", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 16, "acquisition_count": 7, "disposal_count": 9, "acquisition_value": 304122.45, "acquisition_value_label": "$304.1K", "disposal_value": 1272336.028, "disposal_value_label": "$1.3M", "net_value": -968213.578, "net_value_label": "$-968.2K", "flow_tone": "negative", "largest_value_label": "$547.8K", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 16, "value": "1576458.4780", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.6M"}], "days": [{"transaction_date": "2026-06-29", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}, {"transaction_date": "2026-06-30", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 50.0}, {"transaction_date": "2026-07-01", "acquisitions": 4, "disposals": 2, "total": 6, "bar_width": 100.0}, {"transaction_date": "2026-07-08", "acquisitions": 1, "disposals": 3, "total": 4, "bar_width": 66.7}], "side_mix": {"acquisitions": 7, "disposals": 9, "acquisition_share": 43.8, "disposal_share": 56.2}}, "company_flows": [{"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "acquisitions": 7, "disposals": 9, "acquired_value": 304122.45, "acquired_value_label": "$304.1K", "disposed_value": 1272336.028, "disposed_value_label": "$1.3M", "net_value": -968213.578, "net_value_label": "$-968.2K", "acquisition_share": 43.8, "disposal_share": 56.2, "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}], "company_overview": [{"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "filings": 16, "acquisitions": 7, "disposals": 9, "acquired_value": 304122.45, "acquired_value_label": "$304.1K", "disposed_value": 1272336.028, "disposed_value_label": "$1.3M", "net_value": -968213.578, "net_value_label": "$-968.2K", "acquisition_share": 43.8, "disposal_share": 56.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}], "transactions": [{"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "TORLEY, HELEN", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1035.0, "share_price": 80.187, "transaction_value": 82993.545, "fetched_at": "2026-07-28T22:09:15.633840+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "TORLEY, HELEN", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 888.0, "share_price": 79.276, "transaction_value": 70397.088, "fetched_at": "2026-07-28T22:09:15.622989+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "TORLEY, HELEN", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Option to Purchase Common Stock", "side_code": "D", "side": "Disposal", "shares": 1923.0, "share_price": 12.07, "transaction_value": 23210.61, "fetched_at": "2026-07-28T22:09:15.631638+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-08", "executive": "TORLEY, HELEN", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1923.0, "share_price": 12.07, "transaction_value": 23210.61, "fetched_at": "2026-07-28T22:09:15.628034+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "CONNAUGHTON, BERNADETTE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1000.0, "share_price": 76.395, "transaction_value": 76395.0, "fetched_at": "2026-07-21T22:04:38.067984+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "CONNAUGHTON, BERNADETTE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 625.0, "share_price": 77.209, "transaction_value": 48255.625, "fetched_at": "2026-07-21T22:04:38.066342+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "RAMSAY, DAVID A", "executive_title": "EVP, PRESIDENT, DRUG DELIVERY", "security_type": "Option to Purchase Common Stock", "side_code": "A", "side": "Acquisition", "shares": 39823.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.072290+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "RAMSAY, DAVID A", "executive_title": "EVP, PRESIDENT, DRUG DELIVERY", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 16232.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.065038+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SNELLGROVE, DARREN", "executive_title": "SVP,  Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 41554.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.070899+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "SNELLGROVE, DARREN", "executive_title": "SVP,  Chief Financial Officer", "security_type": "Option to Purchase Common Stock", "side_code": "A", "side": "Acquisition", "shares": 127432.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.069366+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "RAMSAY, DAVID A", "executive_title": "EVP, PRESIDENT, DRUG DELIVERY", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5408.0, "share_price": 78.27, "transaction_value": 423284.16, "fetched_at": "2026-07-21T22:04:38.073865+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "RAMSAY, DAVID A", "executive_title": "EVP, PRESIDENT, DRUG DELIVERY", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.075373+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "RAMSAY, DAVID A", "executive_title": "EVP, PRESIDENT, DRUG DELIVERY", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:04:38.077052+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "KRISHNAN, MAHESH", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 7304.0, "share_price": 75.0, "transaction_value": 547800.0, "fetched_at": "2026-07-20T10:55:09.292506+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "KRISHNAN, MAHESH", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7304.0, "share_price": 38.46, "transaction_value": 280911.84, "fetched_at": "2026-07-20T10:55:09.296137+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}, {"symbol": "HALO", "name": "Halozyme Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "KRISHNAN, MAHESH", "executive_title": "Director", "security_type": "Option to Purchase Common Stock", "side_code": "D", "side": "Disposal", "shares": 7304.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T10:55:09.294330+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/halo/", "research_links": {"chart": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/", "report": "/terminal/536f3d46-94f4-4a15-87b0-33746efc4669/report/", "factor": "/factors/ticker/536f3d46-94f4-4a15-87b0-33746efc4669/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}